This article forms a book chapter in Artificial Intelligence in Drug Design.
In this review article, we provide the latest insights into fighting COVID-19 with technologies such as artificial intelligence.
It includes:
- an overview of the ongoing demand for efficacious drugs to treat potential vaccine-resistant COVID-19 variants in the future
- how identifying and repurposing marketed drugs for the treatment of COVID-19 plays an important role in this process
- how artificial intelligence can be employed to speed up the drug discovery process by facilitating the selection of potential drug candidates as well as monitoring the pandemic and enabling faster diagnosis in patients
- a focus on the impact and challenges associated with artificial intelligence for drug repurposing of therapies for the treatment of COVD-19